One in 25 deaths worldwide is related to liver disease, and often with multiple hepatosplenic conditions. Yet, little is understood of the risk factors for hepatosplenic multimorbidity, especially in the context of chronic infections. We present a novel Bayesian multitask learning framework to jointly model 45 hepatosplenic conditions assessed using point-of-care B-mode ultrasound for 3155 individuals aged 5-91 years within the SchistoTrack cohort across rural Uganda where chronic intestinal schistosomiasis is endemic. We identified distinct and shared biomedical, socioeconomic, and spatial risk factors for individual conditions and hepatosplenic multimorbidity, and introduced methods for measuring condition dependencies as risk factors. Notably, for gastro-oesophageal varices, we discovered key risk factors of older age, lower hemoglobin concentration, and severe schistosomal liver fibrosis. Our findings provide a compendium of risk factors to inform surveillance, triage, and follow-up, while our model enables improved prediction of hepatosplenic multimorbidity, and if validated on other systems, general multimorbidity.

ObjectiveThis study aims to enhance breast cancer diagnosis by developing an automated deep learning framework for real-time, quantitative ultrasound imaging. Breast cancer is the second leading cause of cancer-related deaths among women, and early detection is crucial for improving survival rates. Conventional ultrasound, valued for its non-invasive nature and real-time capability, is limited by qualitative assessments and inter-observer variability. Quantitative ultrasound (QUS) methods, including Nakagami imaging--which models the statistical distribution of backscattered signals and lesion morphology--present an opportunity for more objective analysis. MethodsThe proposed framework integrates three convolutional neural networks (CNNs): (1) NakaSynthNet, synthesizing quantitative Nakagami parameter images from B-mode ultrasound; (2) SegmentNet, enabling automated lesion segmentation; and (3) FeatureNet, which combines anatomical and statistical features for classifying lesions as benign or malignant. Training utilized a diverse dataset of 110,247 images, comprising clinical B-mode scans and various simulated examples (fruit, mammographic lesions, digital phantoms). Quantitative performance was evaluated using mean squared error (MSE), structural similarity index (SSIM), segmentation accuracy, sensitivity, specificity, and area under the curve (AUC). ResultsNakaSynthNet achieved real-time synthesis at 21 frames/s, with MSE of 0.09% and SSIM of 98%. SegmentNet reached 98.4% accuracy, and FeatureNet delivered 96.7% overall classification accuracy, 93% sensitivity, 98% specificity, and an AUC of 98%. ConclusionThe proposed multi-parametric deep learning pipeline enables accurate, real-time breast cancer diagnosis from ultrasound data using objective quantitative imaging. SignificanceThis framework advances the clinical utility of ultrasound by reducing subjectivity and providing robust, multi-parametric information for improved breast cancer detection.

BackgroundCarotid plaque presence is associated with cardiovascular risk, even among asymptomatic individuals. While deep learning has shown promise for carotid plaque phenotyping in patients with advanced atherosclerosis, its application in population-based settings of asymptomatic individuals remains unexplored. MethodsWe developed a YOLOv8-based model for plaque detection using carotid ultrasound images from 19,499 participants of the population-based UK Biobank (UKB) and fine-tuned it for external validation in the BiDirect study (N = 2,105). Cox regression was used to estimate the impact of plaque presence and count on major cardiovascular events. To explore the genetic architecture of carotid atherosclerosis, we conducted a genome-wide association study (GWAS) meta-analysis of the UKB and CHARGE cohorts. Mendelian randomization (MR) assessed the effect of genetic predisposition to vascular risk factors on carotid atherosclerosis. ResultsOur model demonstrated high performance with accuracy, sensitivity, and specificity exceeding 85%, enabling identification of carotid plaques in 45% of the UKB population (aged 47-83 years). In the external BiDirect cohort, a fine-tuned model achieved 86% accuracy, 78% sensitivity, and 90% specificity. Plaque presence and count were associated with risk of major adverse cardiovascular events (MACE) over a follow-up of up to seven years, improving risk reclassification beyond the Pooled Cohort Equations. A GWAS meta-analysis of carotid plaques uncovered two novel genomic loci, with downstream analyses implicating targets of investigational drugs in advanced clinical development. Observational and MR analyses showed associations between smoking, LDL cholesterol, hypertension, and odds of carotid atherosclerosis. ConclusionsOur model offers a scalable solution for early carotid plaque detection, potentially enabling automated screening in asymptomatic individuals and improving plaque phenotyping in population-based cohorts. This approach could advance large-scale atherosclerosis research. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=131 SRC="FIGDIR/small/24315675v2_ufig1.gif" ALT="Figure 1"> View larger version (33K): [email protected]@27a04corg.highwire.dtl.DTLVardef@18cef18org.highwire.dtl.DTLVardef@1a53d8f_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGRAPHICAL ABSTRACT.C_FLOATNO ASCVD - Atherosclerotic Cardiovascular Disease, CVD - Cardiovascular disease, PCE - Pooled Cohort Equations, TP- true positive, FN - False Negative, FP - False Positive, TN - True Negative, GWAS - Genome-Wide Association Study. C_FIG CLINICAL PERSPECTIVECarotid ultrasound is a well-established method for assessing subclinical atherosclerosis with potential to improve cardiovascular risk assessment in asymptomatic individuals. Deep learning could automate plaque screening and enable processing of large imaging datasets, reducing the need for manual annotation. Integrating such large-scale carotid ultrasound datasets with clinical, genetic, and other relevant data can advance cardiovascular research. Prior studies applying deep learning to carotid ultrasound have focused on technical tasks-plaque classification, segmentation, and characterization-in small sample sizes of patients with advanced atherosclerosis. However, they did not assess the potential of deep learning in detecting plaques in asymptomatic individuals at the population level. We developed an efficient deep learning model for the automated detection and quantification of early carotid plaques in ultrasound imaging, primarily in asymptomatic individuals. The model demonstrated high accuracy and external validity across population-based cohort studies. Predicted plaque prevalence aligned with known cardiovascular risk factors. Importantly, predicted plaque presence and count were associated with future cardiovascular events and improved reclassification of asymptomatic individuals into clinically meaningful risk categories. Integrating our model predictions with genetic data identified two novel loci associated with carotid plaque presence--both previously linked to cardiovascular disease--highlighting the models potential for population-scale atherosclerosis research. Our model provides a scalable solution for automated carotid plaque phenotyping in ultrasound images at the population level. These findings support its use for automated screening in asymptomatic individuals and for streamlining plaque phenotyping in large cohorts, thereby advancing research on subclinical atherosclerosis in the general population.

Breast cancer is a leading malignancy threatening womens health globally, making early and accurate diagnosis crucial. Ultrasound is a key screening and diagnostic tool due to its non- invasive, real-time, and cost-effective nature. However, its diagnostic accuracy is highly dependent on operator experience, and conventional single-image analysis often fails to capture the comprehensive features of a lesion. This study introduces a computer-aided diagnosis (CAD) system that emulates a clinicians multi-view diagnostic process. We developed a novel hybrid deep learning model that integrates a Convolutional Neural Network (CNN) with a Transformer architecture. The model uses a pretrained EfficientNetV2 to extract spatial features from multiple, unordered ultrasound images of a single lesion. These features are then processed by a Transformer encoder, whose self-attention mechanism globally models and fuses their intrinsic correlations. A strict lesion-level data partitioning strategy ensured a rigorous evaluation. On an internal test set, our CNN-Transformer model achieved an accuracy of 0.93, a sensitivity of 0.92, a specificity of 0.94, and an Area Under the Curve (AUC) of 0.98. On an external test set, it demonstrated an accuracy of 0.93, a sensitivity of 0.94, a specificity of 0.91, and an AUC of 0.97. These results significantly outperform those of a baseline single-image model, which achieved accuracies of 0.88 and 0.89 and AUCs of 0.95 and 0.94 on the internal and external test sets, respectively. This study confirms that combining CNNs with Transformers yields a highly accurate and robust diagnostic system for breast ultrasound. By effectively fusing multi-view information, our model aligns with clinical logic and shows immense potential for improving diagnostic reliability.

Background and AimsEchocardiography serves as a cornerstone of cardiovascular diagnostics through multiple standardized imaging views. While recent AI foundation models demonstrate superior capabilities across cardiac imaging tasks, their massive computational requirements and reliance on large-scale datasets create accessibility barriers, limiting AI development to well-resourced institutions. Vector embedding approaches offer promising solutions by leveraging compact representations from original medical images for downstream applications. Furthermore, demographic fairness remains critical, as AI models may incorporate biases that confound clinically relevant features. We developed a multi-view encoder framework to address computational accessibility while investigating demographic fairness challenges. MethodsWe utilized the MIMIC-IV-ECHO dataset (7,169 echocardiographic studies) to develop a transformer-based multi-view encoder that aggregates view-level representations into study-level embeddings. The framework incorporated adversarial learning to suppress demographic information while maintaining clinical performance. We evaluated performance across 21 binary classification tasks encompassing echocardiographic measurements and clinical diagnoses, comparing against foundation model baselines with varying adversarial weights. ResultsThe multi-view encoder achieved a mean improvement of 9.0 AUC points (12.0% relative improvement) across clinical tasks compared to foundation model embeddings. Performance remained robust with limited echocardiographic views compared to the conventional approach. However, adversarial learning showed limited effectiveness in reducing demographic shortcuts, with stronger weighting substantially compromising diagnostic performance. ConclusionsOur framework democratizes advanced cardiac AI capabilities, enabling substantial diagnostic improvements without massive computational infrastructure. While algorithmic approaches to demographic fairness showed limitations, the multi-view encoder provides a practical pathway for broader AI adoption in cardiovascular medicine with enhanced efficiency in real-world clinical settings. Structured graphical abstract or graphical abstractO_ST_ABSKey QuestionC_ST_ABSCan multi-view encoder frameworks achieve superior diagnostic performance compared to foundation model embeddings while reducing computational requirements and maintaining robust performance with fewer echocardiographic views for cardiac AI applications? Key FindingMulti-view encoder achieved 12.0% relative improvement (9.0 AUC points) across 21 cardiac tasks compared to foundation model baselines, with efficient 512-dimensional vector embeddings and robust performance using fewer echocardiographic views. Take-home MessageVector embedding approaches with attention-based multi-view integration significantly improve cardiac diagnostic performance while reducing computational requirements, offering a pathway toward more efficient AI implementation in clinical settings. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/25333725v1_ufig1.gif" ALT="Figure 1"> View larger version (22K): [email protected]@a75818org.highwire.dtl.DTLVardef@88a588org.highwire.dtl.DTLVardef@12bad06_HPS_FORMAT_FIGEXP M_FIG C_FIG Translational PerspectiveOur proposed multi-view encoder framework overcomes critical barriers to the widespread adoption of artificial intelligence in echocardiography. By dramatically reducing computational requirements, the multi-view encoder approach allows smaller healthcare institutions to develop sophisticated AI models locally. The framework maintains robust performance with fewer echocardiographic examinations, which addresses real-world clinical constraints where comprehensive imaging is not feasible due to patient factors or time limitations. This technology provides a practical way to democratize advanced cardiac AI capabilities, which could improve access to cardiovascular care across diverse healthcare settings while reducing dependence on proprietary datasets and massive computational resources.

BackgroundIron overload promotes atherosclerosis in mice and causes vascular dysfunction in humans with Hemochromatosis. However, data are controversial on whether systemic iron availability within physiological limits affects the pathogenesis of atherosclerosis. We, therefore, performed an individual participant data (IPD) meta-analysis and studied the association between serum iron biomarkers with common carotid intima-media thickness (CC-IMT); in addition, since sex influences iron metabolism and vascular aging, we studied if there are sex-specific differences. MethodsWe pooled the IPD and analysed the data on adults (age[&ge;]18y) by orthogonal approaches: machine learning (ML) and a single-stage meta-analysis. For ML, we tuned a gradient-boosted tree regression model (XGBoost) and subsequently, we interpreted the features using variable importance. For the single-stage metaanalysis, we examined the association between iron biomarkers and CC-IMT using spline-based linear mixed models, accounting for sex interactions and study-specific effects. To confirm robustness, we repeated analyses on imputed data using multivariable regression adjusted for key covariates identified through machine learning. Further, subgroup analyses were performed in children and adolescents (age<18y). In addition, to evaluate causality, we used UK Biobank data to examine associations between the hemochromatosis (HFE) genotypes (C282Y/H63D) and mean CC-IMT in [~]42,500 participants with carotid ultrasound data, using sex-stratified linear regression (adjusted for age, assessment centre, and genetic principal components). ResultsWe included IPD from 21 studies (N=10,807). The application of the ML model showed moderate predictive performance and identified iron biomarkers (transferrin, ferritin, transferrin saturation, and iron) as key features for IMT prediction. Multivariable analyses showed non-linear sex-specific relationships for ferritin and transferrin with CC-IMT: ferritin showed a significant positive association, and transferrin showed negative associations at specific ranges, both only among females. No significant associations were found between CC-IMT in those with HFE genotypes in either sex in the UK Biobank. ConclusionOur observational data show that iron biomarkers - ferritin and transferrin are non-linearly associated with CC-IMT specifically in females, while a significant causal association between the HFE genotype and CC-IMT could not be demonstrated in the UK Biobank data. We conclude that the observational associations may not only be explained by causal effects of iron on the arterial wall thickness, but also in part be driven by residual confounding factors such as inflammation. Other: No financial support was received for this meta-analysis. The protocol for this study is registered in the PROSPERO database (CRD42020155429; https://www.crd.york.ac.uk/).

BackgroundKawasaki disease (KD) is an acute, pediatric vasculitis associated with coronary artery abnormality (CAA) development. Echocardiography at month 1 post-diagnosis remains the standard for CAA surveillance despite limitations, including patient distress and increased healthcare burden. With declining CAA incidence due to improved treatment, the need for routine follow-up imaging is being reconsidered. This study aimed to develop and externally validate models for predicting CAA development and guide the need for echocardiography. MethodsThis study used two prospective multicenter Japanese registries: PEACOCK for model development and internal validation, and Post-RAISE for external validation. The primary outcome was CAA at the month 1 follow-up, defined as a maximum coronary artery Z score (Zmax) [&ge;] 2. Twenty-nine clinical, laboratory, echocardiographic, and treatment-related variables obtained within one week of diagnosis were selected as predictors. The models included simple models using the previous Zmax as a single predictor, logistic regression models, and machine learning models (LightGBM and XGBoost). Their discrimination, calibration, and clinical utility were assessed. ResultsAfter excluding patients without outcome data, 4,973 and 2,438 patients from PEACOCK and Post-RAISE, respectively, were included. The CAA incidence at month 1 was 5.5% and 6.8% for the respective group. For external validation, a simple model using the Zmax at week 1 produced an area under the curve of 0.79, which failed to improve by more than 0.02 after other variables were added or more complex models were used. Even the best-performing models with a highly sensitive threshold failed to reduce the need for echocardiography at month 1 by more than 30% while maintaining the number of undiagnosed CAA cases to less than ten. The predictive performance declined considerably when the Zmax was omitted from the multivariable models. ConclusionsThe Zmax at week 1 was the strongest predictor of CAA at month 1 post-diagnosis. Even advanced models incorporating additional variables failed to achieve a clinically acceptable trade-off between reducing the need for echocardiography and reducing the number of undiagnosed CAA cases. Until superior predictors are identified, echocardiography at month 1 should remain the standard practice. Clinical PerspectiveO_ST_ABSWhat Is New?C_ST_ABSO_LIThe maximum Z score on echocardiography one week after diagnosis was the strongest of 29 variables for predicting coronary artery abnormalities (CAA) in patients with Kawasaki disease. C_LIO_LIEven the most sensitive models had a suboptimal ability to predict CAA development and reduce the need for imaging studies, suggesting they have limited utility in clinical decision-making. C_LI What Are the Clinical Implications?O_LIUntil more accurate predictors are found or imaging strategies are optimized, performing echocardiography at one-month follow-up should remain the standard of care. C_LI

PurposeTo develop and validate an artificial intelligence (AI)-based model that automatically measures choroidal mass dimensions on B{square}scan ophthalmic ultrasound still images and cine loops. DesignRetrospective diagnostic accuracy study with internal and external validation. ParticipantsThe dataset included 1,822 still images and 283 cine loops of choroidal masses for model development and testing. An additional 182 still images were used for external validation, and 302 control images with other diagnoses were included to assess specificity MethodsA deep convolutional neural network (CNN) based on the U-Net architecture was developed to automatically measure the apical height and basal diameter of choroidal masses on B-scan ultrasound. All still images were manually annotated by expert graders and reviewed by a senior ocular oncologist. Cine loops were analyzed frame by frame and the frame with the largest detected mass dimensions was selected for evaluation. Outcome MeasuresThe primary outcome was the models measurement accuracy, defined by the mean absolute error (MAE) in millimeters, compared to expert manual annotations, for both apical height and basal diameter. Secondary metrics included the Dice coefficient, coefficient of determination (R2), and mean pixel distance between predicted and reference measurements. ResultsOn the internal test set of still images, the model successfully detected the tumor in 99.7% of cases. The mean absolute error (MAE) was 0.38 {+/-} 0.55 mm for apical height (95.1% of measurements <1 mm of the expert annotation) and was 0.99 {+/-} 1.15 mm for basal diameter (64.4% of measurements <1 mm). Linear agreement between predicted and reference measurements was strong, with R2 values of 0.74 for apical height and 0.89 for basal diameter. When applied to the control set of 302 control images, the model demonstrated a moderate false positive rate. On the external validation set, the model maintained comparable accuracy. Among the cine loops, the model detected tumors in 89.4% of cases with comparable accuracy. ConclusionDeep learning can deliver fast, reproducible, millimeter{square}level measurements of choroidal mass dimensions with robust performance across different mass types and imaging sources. These findings support the potential clinical utility of AI-assisted measurement tools in ocular oncology workflows.

BackgroundPericardial disease exhibits a wide clinical spectrum, ranging from mild effusions to life-threatening tamponade or constriction pericarditis. While transthoracic echocardiography (TTE) is the primary diagnostic modality, its effectiveness is limited by operator dependence and incomplete evaluation of functional impact. Existing artificial intelligence models focus primarily on effusion detection, lacking comprehensive disease assessment. MethodsWe developed a deep learning (DL)-based framework that sequentially assesses pericardial disease: (1) morphological changes, including pericardial effusion amount (normal/small/moderate/large) and pericardial thickening or adhesion (yes/no), using five B-mode views, and (2) hemodynamic significance (yes/no), incorporating additional inputs from Doppler and inferior vena cava measurements. The developmental dataset comprises 2,253 TTEs from multiple Korean institutions (225 for internal testing), and the independent external test set consists of 274 TTEs. ResultsIn the internal test set, the model achieved diagnostic accuracy of 81.8-97.3% for pericardial effusion classification, 91.6% for pericardial thickening/adhesion, and 86.2% for hemodynamic significance. Corresponding accuracy in the external test set was 80.3-94.2%, 94.5%, and 85.5%, respectively. Area under the receiver operating curves (AUROCs) for the three tasks in the internal test set was 0.92-0.99, 0.90, and 0.79; and in the external test set, 0.95-0.98, 0.85, and 0.76. Sensitivity for detecting pericardial thickening/adhesion and hemodynamic significance was modest (66.7% and 68.8% in the internal test set), but improved substantially when cases with poor image quality were excluded (77.3%, and 80.8%). Similar performance gains were observed in subgroups with complete target views and a higher number of available video clips. ConclusionsThis study presents the first DL-based TTE model capable of comprehensive evaluation of pericardial disease, integrating both morphological and functional assessments. The proposed framework demonstrated strong generalizability and aligned with the real-world diagnostic workflow. However, caution is warranted when interpreting results under suboptimal imaging conditions.

This paper addresses the problem of detecting possible serious bacterial infection (pSBI) of infancy, i.e. a clinical presentation consistent with bacterial sepsis in newborn infants using cranial ultrasound (cUS) images. The captured image set for each patient enables multiview imagery: coronal and sagittal, with geometric overlap. To exploit this geometric relation, we develop a new learning framework, called the intersection-guided Crossview Local-and Image-level Fusion Network (CLIF-Net). Our technique employs two distinct convolutional neural network branches to extract features from coronal and sagittal images with newly developed multi-level fusion blocks. Specifically, we leverage the spatial position of these images to locate the intersecting region. We then identify and enhance the semantic features from this region across multiple levels using cross-attention modules, facilitating the acquisition of mutually beneficial and more representative features from both views. The final enhanced features from the two views are then integrated and projected through the image-level fusion layer, outputting pSBI and non-pSBI class probabilities. We contend that our method of exploiting multi-view cUS images enables a first of its kind, robust 3D representation tailored for pSBI detection. When evaluated on a dataset of 302 cUS scans from Mbale Regional Referral Hospital in Uganda, CLIF-Net demonstrates substantially enhanced performance, surpassing the prevailing state-of-the-art infection detection techniques.